INTEGRATED PHARMACEUTICALS INC

General form for quarterly reports under Section 13 or 15(d)

Certification of termination of registration of a class of securities (Section 12(g))

8.01

Notification of late filing of Form 10-Q

Changes in Registrant.s Certifying Accountant

4.01

No description available

Notification of late filing of Form 10-Q

No description available

Notification of late filing of Form 10-K

No description available

Notification of late filing of Form 10-Q

5.02

No description available

5.02,9.01

No description available

Notification of late filing of Form 10-Q

Notice of Effectiveness

Correspondence with the SEC

Letter from the SEC

No description available

No description available

No description available

ITEM INFORMATION:

No description available

Beneficial ownership report for a holder of more than 5% (Schedule 13D) (amendment)

1.01

3.02

Letter from the SEC

No description available

Notification of late filing of Form 10-Q

FILED AS OF DATE: 20060905

No description available

Notification of late filing of Form 10-Q

5.02

ITEM INFORMATION:

ITEM INFORMATION:

No description available

No description available

Notification of late filing of Form 10-K

ITEM INFORMATION:

3.02

Regulation FD Disclosure

No description available

Beneficial ownership report for a holder of more than 5% (Schedule 13D)

Letter from the SEC

06

No description available

06

Letter from the SEC

No description available

Letter from the SEC

No description available

No description available

No description available

Letter from the SEC

No description available

06

ITEM INFORMATION:

06,46

FILED AS OF DATE: 20040323

06

Featherston Peter Smith

SMITH DAVID H

Wlosek Kenneth P

SMITH DAVID H

JOHNSON CHIN SALLY

Wlosek Kenneth P

SMITH DAVID H

JOHNSON CHIN SALLY

SMITH DAVID H

CHATTERJEE CHINMAY

CHATTERJEE NILU PRASAD

FURTADO EDWARD D

SMITH DAVID H

SMITH DAVID H

JOHNSON CHIN SALLY

FURTADO EDWARD D

CHATTERJEE NILU PRASAD

CHATTERJEE CHINMAY